Related Experiment Video

Updated: Jan 11, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

[Cervical cancer screening : implementation of the hr-HPV test]

Sarah Ongaro1, Joëlle Desreux2, Pierre-Luc Tremblay-Lemoine2

  • 1Département de Gynécologie-Obstétrique, CHU Liège, Belgique.

Revue Medicale De Liege
|November 13, 2025
PubMed
Summary

Cervical cancer screening is evolving with human papillomavirus (HPV) testing, aiding early detection and reducing mortality. Primary prevention through vaccination remains crucial for both girls and boys.

Keywords:
Cervical ScreeningGuidelinesHPV test

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
554